
Injectable, Structural Regenerative Implant for Cartilage Care
Protect • Repair • Regenerate
Cartilage injuries can turn simple movement into a challenge. Without timely treatment, damage may progress and increase the risk of arthritis or future joint replacement.
At Liquid Cartilage, our goal isjoint preservation and regeneration—not replacement. WithChondroFiller®, we deliver advanced, evidence-led care on Harley Street.

Cartilage provides the smooth, low-friction surface that lets your joints move comfortably. It doesn’t readily self-repair, but with the right scaffold and biological cues,regeneration is possible.
Act early to preserve more of what you have.

ChondroFiller® is an acellular,biologic collagen scaffold delivered in liquid form. Once placed, itgels within minutes, filling the defect and providing a framework that invites your cells to rebuild cartilage.
Think of it like “epoxy” for cartilage—without the plastic.
One treatment. One step. A chance to keep your joint for the long term.


ChondroFiller® sits in a different class—structural regenerative implant.
| Treatment | Analogy | What it Does | Limitation |
|---|---|---|---|
| HA (Hyaluronic Acid) | WD-40 | Improves lubrication for short-term comfort | Temporary; does not regenerate tissue |
| Arthrosamid® | Silicone | Acts on the synovium to reduce pain signalling | Not regenerative; literature notes complication rates up to 30% |
| ChondroFiller® | Epoxy resin | Fills defects, stabilises, and promotes true cartilage repair | Most robust injectable option for structural repair |
ChondroFiller®: our structural, regenerative approach to focal cartilage defects.
Small joints: thumb, fingers, elbow, AC joint, toes, TMJ…
From £2,100
Large joints: knee, hip, shoulder, ankle
From £2,800
Best for knee, hip, shoulder
From £6,500 (knee), £9,500 (hip/shoulder)
Our proprietary MSC Co-Delivery Technique
Introductory offer: your consultation fee is credited toward treatment if you proceed.

Quick, no-obligation chat

Comprehensive assessment with Prof. Paul Lee

Injection, Keyhole, or Liquid Cartilage™

Precise and minimally invasive



Cartilage damage won’t reverse on its own—yet with the right plan it can beprotected, repaired, and regenerated.
At Liquid Cartilage, you access world-leading science and a joint-preservation vision on Harley Street.
(Consultation fee credited towards treatment if you proceed.)
Everything you want to know about ChondroFiller® at Liquid Cartilage.
ChondroFiller® is an acellular collagen gel that fills cartilage defects and forms a scaffold for your own cells to regenerate healthy tissue. Unlike temporary injections, it supports hyaline-like restorationfor smoother motion and protection long-term.
HA or Arthrosamid® may give short-term pain relief, while ChondroFiller® aims to rebuild cartilage. Compared with replacement, it preserves your natural joint and avoids prosthesis risks. Our approach is regenerate-first.
Studies show +30 IKDC in knees,+33 Harris Hip Score in hips, and improved ankle metrics. MRI (MOCART) typically reads 70–87. Globally,>19,000 cases support safety and function.
Best for focal defects up to 6 cm² in knees, hips, ankles, or small joints. Active younger patients often benefit, but older patients may qualify if surrounding cartilage is stable.
Delivered via precise injection orkeyhole surgery. The gel sets in minutes. Expectpartial weight-bearing ~6 weeks, steady return to cycling/swimming, and most sports around~12 months alongside specialist rehab.
Harley Street location; UK ICRS Centre of Excellence. Led byProf. Paul Lee, with advanced options likeLiquid Cartilage™ (ChondroFiller® + cells) to prioritise preservation.
Discover what makes ChondroFiller® unique at Liquid Cartilage.

Liquid Cartilage™, meaning ChondroFiller™, is an arthroscopic collagen matrix used for localised hip or ankle cartilage defects, not diffuse osteoarthritis. In a small 2021 hip cohort, 17 of 21 patients available at 3 to 5 years had good or excellent results, but ankle evidence remains thinner than for microfracture.

Cartilage repair choice is driven first by defect size, joint and damage pattern: smaller isolated lesions tend towards OATS or scaffold-based repair, while larger symptomatic defects more often need AMIC, MACI or OCA. In the knee, MACI outperformed microfracture at 2 and 5 years for larger defects.

Knee OCD has no single countdown clock; the preservation window is the stable-lesion stage before instability or detachment, with MRI and clinical assessment driving decisions. In children with open growth plates, stable lesions are often given a 3- to 6-month joint-preserving trial because healing remains plausible.

Liquid Cartilage™ is considered for a defined symptomatic cartilage defect treated arthroscopically, not for diffuse joint wear: ChondroFiller™ is a cell-free type I collagen scaffold placed into the defect and sets into a hydrogel in about 3–5 minutes.

Early knee osteoarthritis sits in a grey zone: X-rays can be normal or only mildly abnormal while cartilage, meniscal or bone-marrow damage is already present. A preservation window is usually still open in mild-to-moderate disease, but only after ruling out other causes of pain and stiffness.

Cartilage damage on a scan matters most when it lines up with ongoing symptoms — persistent pain, recurrent swelling, catching, locking, giving way or lost movement — rather than as an isolated finding. Across the knee, hip and ankle, focal symptomatic defects usually need specialist assessment: a knee with a focal lesion on MRI that keeps swelling and clicking, a hip with deep groin pain and a labral tear that does not self-repair, or a painful or unstable talar lesion after injury all warrant review. Conservative care and watchful waiting can be enough when a lesion is stable and symptoms settle, particularly in children with nondisplaced talar lesions, but a defect that matches the clinical pattern rarely heals on its own.